MIT’s new ‘recursive’ framework lets LLMs process 10 million tokens without context rot

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...
eWeek

MIT Just Solved AI’s Memory Problem (And It’s Brilliantly Simple)

MIT’s Recursive Language Models rethink AI memory by treating documents like searchable environments, enabling models to ...
Daily Excelsior

Machine Learning Methods Used for Portfolio Optimization and Risk Management

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...
eWeek

Apple’s iPhone Air Designer Abidur Chowdhury Moves to AI Startup Hark

Apple designer Abidur Chowdhury has left the company behind the iPhone Air to join AI startup Hark, signaling a growing shift ...

Vibrant’s New Title Empowers Emerging Developers With the Foundations of Efficient, Real-World Programming

Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...
InfoQ

MIT's Recursive Language Models Improve Performance on Long-Context Tasks

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance ...
pharmaphorum

Recursion, Exscientia, and AI drug discovery’s moment of truth

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Investing

Recursion Pharmaceuticals Inc (RXRX)

Wednesday’s market has seen notable movements in various stocks due to news and other factors. Today, stocks like Avago... Wednesday’s market has seen swings in various stocks based on news and other ...
Hosted on MSN

Cathie Wood’s ARK Investment buys 755K shares of Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 12 Best Genomics Stocks to Invest In. Cathie Wood’s ARK Investment acquired 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...